Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors), p38α stimulants(P38 α mitogen-activated protein kinase stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Preclinical | CN | 15 Apr 2021 |